Skip to main content
Terug
MCK logo

McKesson Corporation

Datakwaliteit: 100%
MCK
NYSE Healthcare Medical - Distribution
€ 881,94
▲ € 4,93 (0,56%)
Marktkapitalisatie: 108,85B
Dagbereik
€ 864,78 € 887,17
52-Weeksbereik
€ 637,00 € 999,00
Volume
697.003
50D / 200D Gem.
€ 901,13 / € 793,07
Vorige Slotkoers
€ 877,01

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (627 peers)

Metriek Aandeel Sector Mediaan
P/E 33,0 0,4
P/B 2,9
ROE % 3,7
Net Margin % 0,9 3,9
Rev Growth 5Y % 10,8 10,0
D/E 0,2

Koersdoel Analisten

Hold
€ 982,38 +11.4%
Low: € 900,00 High: € 1.085,00
Forward K/W
22,5
Forward WPA
€ 39,02
WPA Groei (sch.)
+0,0%
Omzet Sch.
410 B

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2030 € 67,19
€ 65,82 – € 68,64
550 B 1
FY2029 € 57,69
€ 56,51 – € 58,93
510 B 1
FY2028 € 50,00
€ 49,01 – € 51,43
480 B 3

Insider Trading Activity

Buy ratio (90d) 0.0%
20 transactions
Date Insider Type Shares Price Value
Mar 2, 2026
Lau Michele
EVP and Chief Legal Officer
sell 2.725 € 990,00 € 2.697.750
Feb 17, 2026
Smith LeAnn B
EVP & Chief HR Officer
sell 190 € 945,00 € 179.550
Aug 22, 2025
TYLER BRIAN S.
Chief Executive Officer
sell 11.930 € 705,63 € 8.418.166
Aug 15, 2025
TYLER BRIAN S.
Chief Executive Officer
sell 11.930 € 677,76 € 8.085.677
Jul 30, 2025
OZAN KEVIN M
Director
grant 301
Jul 30, 2025
Hinton James H.
Director
grant 301
Jul 11, 2025
TYLER BRIAN S.
Chief Executive Officer
sell 19.371 € 708,09 € 13.716.411
Jun 10, 2025
TYLER BRIAN S.
Chief Executive Officer
other 4.000
Jun 6, 2025
TYLER BRIAN S.
Chief Executive Officer
sell 19.370 € 705,93 € 13.673.864
May 30, 2025
Rodgers Thomas L
EVP, Chief Strategy & BDO
sell 2.891 € 712,18 € 2.058.912
May 28, 2025
Rodgers Thomas L
EVP, Chief Strategy & BDO
sell 510 € 717,91 € 366.134
May 28, 2025
Vitalone Britt J.
EVP & CFO
sell 1.878 € 717,91 € 1.348.235
May 28, 2025
Smith LeAnn B
EVP & Chief HR Officer
sell 341 € 717,91 € 244.807
May 27, 2025
Rutledge Napoleon B JR
SVP, Controller & CAO
sell 986 € 714,30 € 704.300
May 23, 2025
Rutledge Napoleon B JR
SVP, Controller & CAO
other 313
May 23, 2025
Rutledge Napoleon B JR
SVP, Controller & CAO
sell 63 € 715,24 € 45.060
May 22, 2025
Vitalone Britt J.
EVP & CFO
sell 6.336 € 717,30 € 4.544.813
May 21, 2025
Lau Michele
EVP and Chief Legal Officer
other 1.733
May 21, 2025
Vitalone Britt J.
EVP & CFO
other 2.889
May 20, 2025
Lau Michele
EVP and Chief Legal Officer
grant 2.031

Belangrijkste Punten

Revenue grew 10,80% annually over 5 years — strong growth
Generating 5,23B in free cash flow
P/E of 33,04 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5,42%
Cash machine — converts 158,60% of earnings into free cash flow
Capital efficient — spends only 0,24% of revenue on capex

Groei

Revenue Growth (5Y)
10,80%
Revenue (1Y)16,22%
Earnings (1Y)9,76%
FCF Growth (3Y)6,58%

Kwaliteit

Return on Equity
N/A
ROIC61,68%
Net Margin0,92%
Op. Margin1,22%

Veiligheid

Debt / Equity
N/A
Current Ratio0,90
Interest Coverage17,08

Waardering

P/E Ratio
33,04
P/B RatioN/A
EV/EBITDA25,29
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 16,22% Revenue Growth (3Y) 13,91%
Earnings Growth (1Y) 9,76% Earnings Growth (3Y) -3,79%
Revenue Growth (5Y) 10,80% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 359,05B Net Income (TTM) 3,30B
ROE N/A ROA 4,39%
Gross Margin 3,48% Operating Margin 1,22%
Net Margin 0,92% Free Cash Flow (TTM) 5,23B
ROIC 61,68% FCF Growth (3Y) 6,58%
Safety
Debt / Equity N/A Current Ratio 0,90
Interest Coverage 17,08 Dividend Yield 0,00%
Valuation
P/E Ratio 33,04 P/B Ratio N/A
P/S Ratio 0,30 PEG Ratio 1,77
EV/EBITDA 25,29 Dividend Yield 0,00%
Market Cap 108,85B Enterprise Value 110,55B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 359,05B 308,95B 276,71B 263,97B 238,23B
Net Income 3,30B 3,00B 3,56B 1,11B -4,54B
EPS (Diluted) 25,72 22,39 25,04 7,23 -27,02
Gross Profit 12,49B 12,20B 11,87B 12,65B 11,58B
Operating Income 4,37B 3,93B 4,45B 2,72B 3,51B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 75,14B 67,44B 62,32B 63,30B 65,02B
Total Liabilities 76,83B 69,04B 63,81B 65,09B 63,57B
Shareholders' Equity -2,07B -1,97B -1,86B -2,27B -21,00M
Total Debt 7,39B 7,39B 7,30B 7,54B 9,41B
Cash & Equivalents 5,69B 4,58B 4,68B 3,53B 6,28B
Current Assets 55,40B 47,97B 44,29B 46,23B 45,38B
Current Liabilities 61,60B 52,36B 47,96B 48,47B 44,10B

Strategiescores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#287 of 616
37

Recente Activiteit

Ingestapt Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026